AU4779599A - Methods of inhibiting (helicobacter pylori) - Google Patents

Methods of inhibiting (helicobacter pylori)

Info

Publication number
AU4779599A
AU4779599A AU47795/99A AU4779599A AU4779599A AU 4779599 A AU4779599 A AU 4779599A AU 47795/99 A AU47795/99 A AU 47795/99A AU 4779599 A AU4779599 A AU 4779599A AU 4779599 A AU4779599 A AU 4779599A
Authority
AU
Australia
Prior art keywords
methods
inhibiting
helicobacter pylori
molecules
pylori
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47795/99A
Other languages
English (en)
Inventor
Valerie Cussac
Hilde De Reuse
Agnes Labigne
Stephane Skouloubris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Publication of AU4779599A publication Critical patent/AU4779599A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/58—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving urea or urease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/121—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Helicobacter (Campylobacter) (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AU47795/99A 1998-06-30 1999-06-29 Methods of inhibiting (helicobacter pylori) Abandoned AU4779599A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09107383 1998-06-30
US09/107,383 US6190667B1 (en) 1998-06-30 1998-06-30 Methods of inhibiting Helicobacter pylori
PCT/EP1999/004490 WO2000000634A2 (en) 1998-06-30 1999-06-29 METHODS OF INHIBITING $i(HELICOBACTER PYLORI)

Publications (1)

Publication Number Publication Date
AU4779599A true AU4779599A (en) 2000-01-17

Family

ID=22316366

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47795/99A Abandoned AU4779599A (en) 1998-06-30 1999-06-29 Methods of inhibiting (helicobacter pylori)

Country Status (9)

Country Link
US (5) US6190667B1 (enExample)
EP (1) EP1092040B1 (enExample)
JP (1) JP4445128B2 (enExample)
AT (1) ATE288498T1 (enExample)
AU (1) AU4779599A (enExample)
DE (1) DE69923559T2 (enExample)
ES (1) ES2237119T3 (enExample)
PT (1) PT1092040E (enExample)
WO (1) WO2000000634A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190667B1 (en) * 1998-06-30 2001-02-20 Institut Pasteur Methods of inhibiting Helicobacter pylori
US5942409A (en) * 1998-07-31 1999-08-24 Byk Gulden Lomberg Chemische Fabrik Gmbh Process for identification of substances modulating ureI dependent mechanisms of Helicobacter pylori metabolism
US20030113742A1 (en) * 2001-04-20 2003-06-19 University Of Iowa Research Foundation Methods and compositions for the modulation of biofilm formation
US20070092502A1 (en) * 2005-09-01 2007-04-26 Allergan, Inc. Method of Treating Glaucoma
ATE465928T1 (de) 2005-11-21 2010-05-15 Faroex Ltd Verbundkarosserie für ein fahrzeug
CA2599560C (en) 2006-09-01 2011-04-12 Faroex Ltd. Structural shear plate for a vehicle
DK2270133T3 (en) 2008-04-22 2015-09-07 Corporación Alimentaria Peñasanta Capsa Method of obtaining a new strain of Bifidobacterium bidifum with effect against infection with Helicobacter pylori
CN111471780A (zh) * 2020-03-16 2020-07-31 上海力拜生物科技有限公司 幽门螺杆菌唾液检测生物标志物及其应用
CN117050169B (zh) * 2023-08-14 2024-04-26 苏州东抗生物科技有限公司 一种针对UreA蛋白的单克隆抗体及其应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USH25H (en) 1985-06-17 1986-02-04 Tennessee Valley Authority Thiophosphoryl triamide as a urease inhibitor
FR2637612B1 (fr) 1988-10-06 1993-09-10 Pasteur Institut Sequences de nucleotides codant pour une proteine a activite ureasique
GB8928625D0 (en) 1989-12-19 1990-02-21 3I Res Expl Ltd H.pylori dna probes
JPH04364160A (ja) 1990-08-03 1992-12-16 Terumo Corp チオウレア誘導体およびこれを含有する抗菌剤および抗潰瘍剤
JPH0559038A (ja) 1991-09-06 1993-03-09 Terumo Corp チオウレア誘導体及びこれを含有する医薬製剤
FR2682122B1 (fr) * 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
US5409903A (en) 1992-02-18 1995-04-25 Urecap Corporation Method and compositions for the treatment of H. pylori and dermatitis
US5472695A (en) * 1992-06-25 1995-12-05 Technion Research And Development Foundation Ltd. Therapeutic application of a thyme extract and in - vitro methods for inhibiting the growth and urease activity of helicobacter pylori
MX9304638A (es) 1992-07-31 1994-05-31 Neose Pharm Inc Composicion para tratar e inhibir las ulceras gastricas y duodenales.
US5972336A (en) * 1992-11-03 1999-10-26 Oravax Merieux Co. Urease-based vaccine against helicobacter infection
US6258359B1 (en) * 1993-05-19 2001-07-10 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
JPH08509873A (ja) * 1993-05-19 1996-10-22 アンスティテュ・パストゥール ヘリコバクター感染に対する免疫組成物、該組成物に用いられるポリペプチドおよび該ポリペプチドをコードする核酸配列
US5441875A (en) 1993-07-23 1995-08-15 Brigham And Women's Hospital Urea transporter polypeptide
US5560912A (en) * 1994-06-27 1996-10-01 Technion Research & Development Foundation Ltd. Method for inhibiting growth of helicobacter pylori
DE69637947D1 (de) 1995-04-28 2009-07-23 Merieux Oravax Snc Multimerer, rekombinanter urease impfstoff
DE69636320T2 (de) 1995-06-02 2007-07-26 Eisai R&D Management Co., Ltd. Helicobacter Polypeptide, deren Herstellung und Verwendung
SK165197A3 (en) 1995-06-07 1999-01-11 Astra Ab Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
US6087358A (en) * 1995-06-26 2000-07-11 Pathogenesis Corporation Nitro-[2,1-b]imidazopyran compounds and antibacterial uses thereof
FR2736360B1 (fr) * 1995-07-04 1997-09-05 Pasteur Institut Clonage et caracterisation du gene fiba de h.pylori, production de souches aflagellees
TW290498B (en) * 1995-07-19 1996-11-11 Andover Coated Products Inc Elastic bandage
SE506529C2 (sv) 1996-01-23 1997-12-22 Semper Ab Användning av ett laktoperoxidassystem för framställning av ett läkemedel mot Helicobacter pylori
US5900410A (en) 1996-08-27 1999-05-04 Hartmann; John F. Monotherapy of peptic ulcers and gastritis
EP0939800A2 (en) * 1996-10-17 1999-09-08 Institut Pasteur HELICOBACTER ANTIGEN (gamma-GLUTAMYLTRANSFERASE) AND SEQUENCES ENCODING THE SAME
AU742521B2 (en) * 1997-01-24 2002-01-03 Avi Biopharma, Inc. Method and conjugate for treating H. pylori infection
US5876946A (en) * 1997-06-03 1999-03-02 Pharmacopeia, Inc. High-throughput assay
US5985631A (en) * 1997-09-12 1999-11-16 Oravax-Merieux Co. Method for preventing the activation of inactive, recombinant Helicobacter pylori apourease
US6190667B1 (en) * 1998-06-30 2001-02-20 Institut Pasteur Methods of inhibiting Helicobacter pylori
US5942409A (en) * 1998-07-31 1999-08-24 Byk Gulden Lomberg Chemische Fabrik Gmbh Process for identification of substances modulating ureI dependent mechanisms of Helicobacter pylori metabolism
ES2191470T3 (es) * 1998-10-02 2003-09-01 3M Innovative Properties Co Material compuesto, elastico y estratificado.
US20040142343A1 (en) * 2002-08-16 2004-07-22 Yung-Fu Chang Helicobacter bizzozeronii urease genes and their uses in diagnostic and treatment methods

Also Published As

Publication number Publication date
JP2002519039A (ja) 2002-07-02
DE69923559D1 (de) 2005-03-10
US7517666B2 (en) 2009-04-14
US20040115772A1 (en) 2004-06-17
EP1092040A2 (en) 2001-04-18
WO2000000634A2 (en) 2000-01-06
JP4445128B2 (ja) 2010-04-07
US20020102269A1 (en) 2002-08-01
US20050176077A1 (en) 2005-08-11
DE69923559T2 (de) 2006-02-16
EP1092040B1 (en) 2005-02-02
WO2000000634A3 (en) 2000-04-13
ES2237119T3 (es) 2005-07-16
US6416968B1 (en) 2002-07-09
US6762051B2 (en) 2004-07-13
PT1092040E (pt) 2005-06-30
ATE288498T1 (de) 2005-02-15
US6190667B1 (en) 2001-02-20

Similar Documents

Publication Publication Date Title
DE69939864D1 (de) Ppar-gamma modulatoren
AU2582897A (en) Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation
MY180762A (en) Combination therapy comprising glucose reabsorption inhibitors and ppar modulators.
AU4107300A (en) Polyurethane solutions containing alkoxysilane structural units
WO2001017543A3 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
AU1565300A (en) Anti-germinating method for tubers and bulbs using eugenol and/or isoeugenol
AU2003297318A1 (en) Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 21617, 39228, 49928, 54476.
AU2158601A (en) Antiviral agent for use in treatment of cancer
WO2004058158A3 (en) Treatment of metastatic cancer with the b-subunit of shiga toxin
HK1039449A1 (zh) 治疗多发性硬化的方法
AU4779599A (en) Methods of inhibiting (helicobacter pylori)
WO2002030354A3 (en) Uridine therapy for patients with elevated purine levels
MXPA03010406A (es) Tratamiento novedoso para el desorden obsesivo-compulsivo (ocd) y desordenes relacionados con ocd.
WO2004047757A3 (en) Diagnosing and treating hematopoietic cancers
AU3896899A (en) Compositions for the treatment of tumors, and uses thereof
WO2002062205A3 (en) Methods for diagnosing and treating heart disease
WO2003017817A3 (en) Diagnosis, prevention and treatment of cancer
IL139303A0 (en) Treatment of arthritis and other similar conditions
WO2003028536A3 (en) Methods for diagnosing and treating heart disease
WO2002062204A3 (en) Methods for diagnosing and treating heart disease
AU2002257598A1 (en) Agent for treating diabetes mellitus
IL138117A0 (en) 5-imino-13-deoxy anthracycline derivatives, their uses and processes for preparing them
AU2003249999A1 (en) 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours
WO2003028537A3 (en) Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
MX9802809A (es) Ureasa para el tratamiento de infecciones de helicobacter pylori.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase